Biopharma dealmaking in 2026: The recovery gathers speed in Q2
It’s always darkest before the biotech dawn, and at no time was that more true than last summer, as biotech was experiencing a crisis of confidence. We tracked an industry-wide downturn in expectations during the ...
July 22, 2026 06:45 AM EDT FinancingDealsBioregnum The biotech recovery gathers speed in Q2 John Carroll Editor & Founder It’s always darkest before the biotech dawn, and at no time was that more true than last summer, as biotech was experiencing a crisis of … This article is available only to Premium subscribers Upgrade to Premium for unlimited access and Premium exclusives. UPGRADE LOG IN
comments(0)
5-min edit window · permanent after that